SAM
APYX icon

Silvercrest Asset Management’s Apyx Medical APYX Stock Holding History

Silvercrest Asset Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-344,355
Closed -$1.24M – 751
2020
Q1 		$1.24M Sell
344,355
-281,309
-45% -$1.89M 0.01% 476
2019
Q4 		$5.29M Sell
625,664
-26,762
-4% -$193K 0.04% 334
2019
Q3 		$4.42M Buy
+652,426
New +$4.63M 0.04% 359

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Silvercrest Asset Management's APYX Position: Q2 2020 in Review

Silvercrest Asset Management sold out of Apyx Medical (APYX) in Q2 2020, closing a stake of 344,355 shares — an estimated $1.24M sold.

Silvercrest Asset Management first reported a position in APYX in Q3 2019 and held it in 3 quarters. The position peaked at $5.29M in Q4 2019. 62 funds tracked by Wall St. Rank hold APYX as of Q2 2020.

  • Silvercrest Asset Management reported no remaining Apyx Medical position as of Q2 2020 after selling out during the quarter.
  • Silvercrest Asset Management sold 344,355 Apyx Medical shares in Q2 2020, an estimated $1.24M.
  • Silvercrest Asset Management first reported a position in Apyx Medical in Q3 2019 and held it in 3 quarters.
  • Silvercrest Asset Management's Apyx Medical position peaked at $5.29M in Q4 2019.
  • 62 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2020.

Based on Silvercrest Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.